EcoR1 Capital’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $206M | Hold |
|
|||||
|
2025
Q1 | $260M | Buy |
|
|||||
|
2024
Q4 | $379M | Hold |
|
|||||
|
2024
Q3 | $343M | Buy |
|
|||||
|
2024
Q2 | $445M | Buy |
|
|||||
|
2024
Q1 | $668M | Buy |
|
|||||
|
2023
Q4 | $669M | Buy |
|
|||||
|
2023
Q3 | $415M | Buy |
|
|||||
|
2023
Q2 | $497M | Hold |
|
|||||
|
2023
Q1 | $360M | Buy |
|
|||||
|
2022
Q4 | $268M | Hold |
|
|||||
|
2022
Q3 | $354M | Hold |
|
|||||
|
2022
Q2 | $234M | Hold |
|
|||||
|
2022
Q1 | $263M | Buy |
|
|||||
|
2021
Q4 | $191M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $23.4M | Sell |
|
|||||
|
2017
Q4 | $24.8M | Buy |
|